ImageneBio (IMA) Net Income (2020 - 2025)
ImageneBio's (IMA) quarterly Net Income came in at -$24.8 million in Q3 2025, down 677.66% year-over-year from $4.3 million in Q3 2024, and down 225.7% quarter-over-quarter from -$7.6 million in Q2 2025.
Analysis
ImageneBio (IMA) Net Income (2020 - 2025) Analysis & Trends
ImageneBio has disclosed Net Income across 6 years of filings, most recently posting -$24.8 million for Q3 2025.
- In Q3 2025, Net Income fell 677.66% year-over-year to -$24.8 million; the TTM figure through Sep 2025 stood at -$55.9 million (down 6.12% YoY), while the FY2024 annual figure was -$49.2 million, up 27.77% from the prior year.
- Net Income came in at -$24.8 million for Q3 2025 at ImageneBio, down from -$7.6 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $2.8 million in Q4 2021 to a low of -$24.8 million in Q3 2025.
- Average Net Income over 5 years is -$13.7 million, with a median of -$14.5 million recorded in 2021.
- Year-over-year, Net Income soared 110.74% in 2021 and tumbled 677.66% in 2025.
- Over 5 years, Net Income stood at $2.8 million in 2021, then plunged by 604.0% to -$14.1 million in 2022, then tumbled by 39.4% to -$19.7 million in 2023, then climbed by 11.06% to -$17.5 million in 2024, then plunged by 41.62% to -$24.8 million in 2025.
- Per Business Quant data, the three most recent Net Income figures were -$24.8 million in Q3 2025, -$7.6 million in Q2 2025, and -$6.1 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.38 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -10.50 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.10 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 601.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -782.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 97.50 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -290.61 Mn |
| 10 | ImageneBio | 42.89 Mn | -92.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -24.75 Mn |
| Jun 30, 2025 | -7.60 Mn |
| Mar 31, 2025 | -6.11 Mn |
| Dec 31, 2024 | -17.48 Mn |
| Sep 30, 2024 | -3.18 Mn |
| Jun 30, 2024 | -13.73 Mn |
| Mar 31, 2024 | -16.15 Mn |
| Dec 31, 2023 | -19.65 Mn |
| Sep 30, 2023 | -17.34 Mn |
| Jun 30, 2023 | -17.12 Mn |
| Mar 31, 2023 | -14.22 Mn |
| Dec 31, 2022 | -14.10 Mn |
| Sep 30, 2022 | -17.34 Mn |
| Jun 30, 2022 | -20.54 Mn |
| Mar 31, 2022 | -16.84 Mn |
| Dec 31, 2021 | 2.80 Mn |
| Sep 30, 2021 | -14.52 Mn |
| Jun 30, 2021 | -12.68 Mn |
| Mar 31, 2021 | -9.72 Mn |
| Dec 31, 2020 | -26.05 Mn |